PMID: 16634469Apr 26, 2006Paper

Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau

American Journal of Alzheimer's Disease and Other Dementias
Rudy J CastellaniMark A Smith

Abstract

In Alzheimer's disease (AD), the major components of senile plaques and neurofibrillary tangles, amyloid-beta and tau, respectively, are thought by many to play a key role in disease initiation and progression. However, herein we propose that rather than being initiators of disease pathogenesis, the lesions that characterize AD, senile plaques and neurofibrillary pathology, occur consequent to oxidative stress and, importantly, function as a primary line of antioxidant defense. Importantly, this paradigm shift in thinking about the role of lesions in disease also provides an explanation for the appearance of both amyloid-beta and tau in control individuals given the increased levels of oxidative stress associated with the aged brain. In AD, oxidative stress is not only high but chronic and is superimposed upon an age-related vulnerable environment. Therefore, one would predict, successfully, an increased lesion load in patients with AD above and beyond that seen in normal aging. The notion that amyloid-beta and tau accumulations indicate adaptation and, likely, physiological processes sheds light on the pathological expression of disease and calls into question the rationale of current therapeutic efforts targeted toward lesion...Continue Reading

References

Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·G PerryV Chau
Apr 28, 1997·Biochemical and Biophysical Research Communications·M F WalterR P Mason
Oct 31, 1998·Nature·M E CalhounM Jucker
Dec 23, 1998·Journal of Neuropathology and Experimental Neurology·R B KnowlesB T Hyman
Feb 4, 1999·Journal of Neurochemistry·N Y CalingasanG E Gibson
Feb 24, 1999·Journal of Neuropathology and Experimental Neurology·R MorschP D Coleman
Apr 28, 1999·Journal of Neuropathology and Experimental Neurology·D G DavisW R Markesbery
Aug 7, 1999·Dementia and Geriatric Cognitive Disorders·J L GerstM A Smith
Nov 24, 1999·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·J M LongD K Ingram
Feb 22, 2000·The Journal of Biological Chemistry·A TakedaM A Smith
Mar 7, 2000·Lancet·G PerryM A Smith
Jul 11, 2000·Journal of Neuropathology and Experimental Neurology·P OdettiM Tabaton
Jul 20, 2000·Cellular and Molecular Neurobiology·F J Ekinci, T B Shea
Nov 18, 2000·Journal of Neuropathology and Experimental Neurology·X ZhuM A Smith
Nov 23, 2000·Journal of Neuropathology and Experimental Neurology·A NunomuraM A Smith
Feb 22, 2001·Free Radical Biology & Medicine·C A RottkampM A Smith
Feb 24, 2001·Annals of the New York Academy of Sciences·M A SmithG Perry
May 30, 2001·Neurobiology of Aging·M N GordonG W Arendash
Aug 7, 2001·Journal of Neuropathology and Experimental Neurology·A NunomuraM A Smith
Oct 26, 2001·Journal of Neurochemistry·X ZhuM A Smith
Jun 5, 2002·Lancet·Mark A SmithGeorge Perry
Sep 6, 2002·Journal of Alzheimer's Disease : JAD·Dennis J. Selkoe
Oct 26, 2002·Free Radical Biology & Medicine·Mark A SmithGeorge Perry
Apr 18, 2003·Lancet·Nancy J Roizen, David Patterson
Jul 13, 2004·Annals of the New York Academy of Sciences·Hyoung-Gon LeeMark A Smith

❮ Previous
Next ❯

Citations

Jan 1, 2008·The Journal of Nutrition, Health & Aging·J R BarrioG Small
Jun 8, 2013·European Journal of Nutrition·Snorri Bjorn RafnssonAntonia Trichopoulou
Dec 25, 2007·Journal of Molecular Neuroscience : MN·Jinfang WuNasser H Zawia
Aug 22, 2007·Rejuvenation Research·P J CrouchI A Trounce
Jan 4, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jinfang WuNasser H Zawia
Feb 18, 2010·International Journal of Molecular Sciences·Chun ShiDavid T Yew
Sep 7, 2007·The International Journal of Biochemistry & Cell Biology·Peter J CrouchColin L Masters
Jun 29, 2012·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Li-Li GuoJin-Shan Shi
Jan 23, 2009·Free Radical Research·Sandra L SiedlakGeorge Perry
Jan 27, 2015·Cellular and Molecular Neurobiology·Michelli Erica Souza FerreiraSandro Percário
Dec 15, 2012·Expert Review of Neurotherapeutics·Jesper HagemeierRobert Zivadinov
Aug 14, 2019·Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews·Madiha Khalid, Mohammad Abdollahi
Mar 5, 2021·The Journal of Biological Chemistry·Frédéric CheclerInger Lauritzen
Nov 14, 2008·Neurobiology of Aging·Meredith N BraskiePaul M Thompson
Feb 28, 2009·Free Radical Biology & Medicine·Nasser H ZawiaFernando Cardozo-Pelaez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.